These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6174722)

  • 21. Evidence for a role of brain serotonergic neurotransmission in avoidance learning.
    Ogren SO
    Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noise stress and the effects of viloxazine (Vivalan), a new antidepressant, on open field activity in rats.
    Cox T; Lee J
    Pharmacol Biochem Behav; 1976 Jun; 4(6):729-30. PubMed ID: 981291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of cortical neuron responses to acetylcholine by viloxazine.
    Jones RS; Roberts MH
    J Pharm Pharmacol; 1979 Feb; 31(2):87-90. PubMed ID: 33258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression.
    O'Connor WT; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):41-51. PubMed ID: 3363165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new animal model for the prediction of antidepressant activity.
    Wren A; van Riezen H; Rigter H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):96-100. PubMed ID: 616925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viloxazine and neurotransmitter function.
    Greenwood DT
    Adv Biochem Psychopharmacol; 1982; 31():287-300. PubMed ID: 6282059
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term administration of atropine, imipramine, and viloxazine alters responsiveness of rat cortical neurones to acetylcholine.
    Jones RS
    Can J Physiol Pharmacol; 1980 May; 58(5):531-5. PubMed ID: 7417880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of 5-hydroxytryptamine, dopamine and noradrenaline in the rat vas deferens in the presence of compound 48/80, veratridine or K+.
    Celuch SM; Sloley BD
    Br J Pharmacol; 1989 Jan; 96(1):77-82. PubMed ID: 2924078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties.
    Yu C; Garcia-Olivares J; Candler S; Schwabe S; Maletic V
    J Exp Pharmacol; 2020; 12():285-300. PubMed ID: 32943948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of viloxazine hydrochloride on cerebral oxidative metabolism in the rat in vitro].
    Dueñas Laita A; García Roldán JL; González JL; Velasco Martín A
    Arch Neurobiol (Madr); 1983; 46(1):23-30. PubMed ID: 6882108
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats.
    van Riezen H; Leonard BE
    Pharmacol Ther; 1990; 47(1):21-34. PubMed ID: 2195555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Emovit and lonetil--behavioral and neurochemical studies].
    Val'dman AV; Danchev ND
    Eksp Med Morfol; 1983; 22(2):59-64. PubMed ID: 6321132
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.
    Jancsár SM; Leonard BE
    Neuropharmacology; 1984 Sep; 23(9):1065-70. PubMed ID: 6083502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of viloxazine on drug-metabolizing enzyme systems after a single administration].
    al-Rifai IM
    Eksp Med Morfol; 1982; 21(4):187-90. PubMed ID: 6759105
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiments of the viloxazine-noradrenaline interaction on the atrium and the isolated ductus defens of the rat. Comparison with imipramine].
    García Morillas M; Puche E; Mundo A; Arias A
    Arch Farmacol Toxicol; 1980 Apr; 6(1):83-8. PubMed ID: 7387207
    [No Abstract]   [Full Text] [Related]  

  • 36. Viloxazine: a review of the literature.
    Ban TA; McEvoy JP; Wilson WH
    Int Pharmacopsychiatry; 1980; 15(2):118-23. PubMed ID: 7002831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The differential effects of viloxazine and imipramine on performance tests: their relationship to behavioural toxicity.
    Amin MM; Khan P; Lehmann HE
    Psychopharmacol Bull; 1980 Jul; 16(3):57-8. PubMed ID: 7403405
    [No Abstract]   [Full Text] [Related]  

  • 38. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.
    Jarosik J; Legutko B; Unsicker K; von Bohlen Und Halbach O
    Exp Neurol; 2007 Mar; 204(1):20-8. PubMed ID: 17059819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of viloxazine hydrochloride (Vivalan) on food intake and obesity in the rat [proceedings].
    Kirby MJ; Pleece SA; Redfern PH
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():36P. PubMed ID: 32291
    [No Abstract]   [Full Text] [Related]  

  • 40. Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
    Lloyd KG; Zivkovic B; Sanger D; Depoortere H; Bartholini G
    J Pharmacol Exp Ther; 1987 Apr; 241(1):245-50. PubMed ID: 3033203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.